[mchannon]

Having read the same book (while on the fourth floor of MDC Brooklyn of all places) I believe the conclusion I read was that they were trying to make it all work with one drop, which was impossible, because of the number of tests they were promising and the low solute concentrations some of those tests had to work with.

But there's a wide gulf between a drop and a 20mL vial. Requiring three drops and claiming half the battery of tests would still be a substantial improvement. That's what they should've done. And I think this new startup can do that.

I interviewed with Theranos toward the very end. I have never been in a place with a bigger show of security, and I've previously worked for years in nuclear weapons laboratories. If this new startup ditches the demonic-possession voice and the arch-military security schtick, and the Wizard of Oz curtain, I might not consider an investment in them as foolhardy as one in Theranos.